Xuerong Bio-Technology backs subsidiary loan, boosts 2025 guarantee program

Shanghai Xuerong Bio-Technology Co., Ltd. has announced progress in its 2025 guarantee program, which was approved at its 2024 annual general meeting. The program allows for a total guarantee limit of 2.09 billion yuan for subsidiaries' financing activities.

The company recently provided a joint and several liability guarantee for its wholly-owned subsidiary, Chengdu Xueguo Gaorong Biotechnology Co., Ltd., for a loan of 10 million yuan from Bank of Chengdu Dujiangyan Branch. This guarantee falls within previously approved limits, negating the need for further board or shareholder review. Chengdu Xueguo Gaorong, with a 100% equity stake from the company and a recent asset-liability ratio of 26.74%, had an existing approved guarantee limit of 60 million yuan for 2025. After this transaction, its available guarantee limit for 2025 stands at 50 million yuan.

As of the announcement date, the company's total approved external guarantee amount, including this latest guarantee, reached 3,231.8796 million yuan. The actual outstanding guarantee balance is 1,027.6373 million yuan, representing 26.66% of the company's 2024 audited total assets and 124.82% of its net assets. The company reported no other external or overdue guarantees, nor any guarantee-related litigation or losses.